Half Year Results 2025-26

AI SummaryClose X

Beximco Pharmaceuticals PLC reported strong half-year results for the period ending December 31, 2025, with net revenue increasing by 15.8% to BDT 27,800.2 million (£170.2 million), driven by a 15.6% rise in domestic sales and a 17.5% increase in export sales. Profit after tax saw a significant jump of 35.6% to BDT 4,794.2 million (£29.3 million), compared to BDT 3,535.0 million (£23.8 million) in the prior year. The second quarter also demonstrated robust growth, with net sales up 13.9% and profit after tax increasing by 29.8%.

Disclaimer*

UK 100

Latest directors dealings